Benzinga | Aug 12, 2021 04:48PM EDT

VistaGen Therapeutics Q1 EPS $(0.04) Up From $(0.07) YoY, Sales $354.10K

VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.04) per share. This is a 42.86 percent increase over losses of $(0.07) per share from the same period last year. The company reported $354.10 thousand in sales this quarter.